Back to top

Tale of the Tape

Zacks Equity Research

aTyr Pharma (LIFE) Looks Good: Stock Adds 5.9% in Session
November 18, 2016

LIFE CBM

Trades from $3

aTyr Pharma Inc. (LIFE - Free Report) was a big mover last session, as the company saw its shares rise almost 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.55 to $3.50 in the past one-month time frame.

In the last 30 days, the company has seen two upward estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting that more solid trading could be ahead for aTyr Pharma. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.      

aTyr Pharma currently carries a Zacks Rank #2 (Buy).

Another well-ranked Bio Medical-Gene stock is Cambrex Corporation (CBM - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is LIFE going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>